Comparative Study
doi: 10.3109/00365597809179977.
On gestagen treatment of advanced prostatic carcinoma
- PMID: 694436
- DOI: 10.3109/00365597809179977
Item in Clipboard
Comparative Study
On gestagen treatment of advanced prostatic carcinoma
Scand J Urol Nephrol.
1978.
Abstract
Depostat treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study the clinical effect on prostatic cancer was, however, disappointing when compared to the well established effect of orchiectomy. The therapeutic failure of Depostat might be related to the incomplete suppression of plasma testosterone compared to that observed after orchiectomy.
Similar articles
-
[Results of treating prostatic adenoma with Depostat].Urol Nefrol (Mosk). 1980 Sep-Oct;(5):34-7. Urol Nefrol (Mosk). 1980. PMID: 6158780 Russian. No abstract available.
-
Depostat for benign prostatic hyperplasia?Drug Ther Bull. 1973 Sep 14;11(19):75-6. Drug Ther Bull. 1973. PMID: 4130364 No abstract available.
-
Progeston therapy for menstrually related aphthae.Int J Oral Surg. 1978 Oct;7(5):463-70. doi: 10.1016/s0300-9785(78)80038-6. Int J Oral Surg. 1978. PMID: 102602 Clinical Trial.
-
[Treatment of advanced prostatic cancer].Lakartidningen. 2000 Aug 9;97(32-33):3466-9. Lakartidningen. 2000. PMID: 11037588 Review. Swedish.
-
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.Prog Clin Biol Res. 1989;303:161-7. Prog Clin Biol Res. 1989. PMID: 2674982 Review. No abstract available.